Biotechnology VALUE FUND II L.P., 10% Owner at Repare Therapeutics Inc. (RPTX), bought 1,995,922 shares at $14.10 ($28.1M) on 2022-01-19, disclosed to the SEC on 2022-01-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.10 | 7,899 | $111K | 0.4% |
| 2 | $14.10 | 7,899 | $111K | 0.4% |
| 3 | $14.10 | 412,264 | $5.8M | 20.7% |
| 4 | $14.10 | 412,264 | $5.8M | 20.7% |
| 5 | $14.10 | 577,798 | $8.1M | 28.9% |
| 6 | $14.10 | 577,798 |
| $8.1M |
| 28.9% |
| Total | $14.10 avg | 1,995,922 | $28.1M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |